Drugs for Scabies (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 27)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Azithromycin |
Approved |
Phase 4 |
|
83905-01-5 |
447043 |
Synonyms:
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
Azadose
AZASITE
Azenil
Azifast
Azigram
Azimakrol
Azithramycine
AZITHROMYCIN
AZITHROMYCIN ANHYDROUS
Azithromycin dihydrate
AZITHROMYCIN HYDRATE
Azithromycin monohydrate
Azithromycin pfizer brand
Azithromycine
Azithromycinum
Azitrocin
Azitromicina
Azitromin
AZYTER
Azythromycin
Bayer brand OF azithromycin dihydrate
CLAMELLE
CP 62993
|
CP-62,993
CP-62993
Dihydrate, azithromycin
Funk brand OF azithromycin dihydrate
Goxal
Hemomycin
Lesvi brand OF azithromycin dihydrate
Mack brand OF azithromycin dihydrate
Monohydrate, azithromycin
Pfizer brand OF azithromycin
Pfizer brand OF azithromycin dihydrate
Pharmacia brand OF azithromycin dihydrate
Sumamed
SUNAMED
Toraseptol
Ultreon
Vinzam
Vita brand OF azithromycin dihydrate
XZ 405
XZ 450
XZ-450
Zentavion
Zithromax
Zitromax
Zmax
|
|
2 |
|
Ivermectin |
Approved, Investigational, Vet_approved |
Phase 4 |
|
70288-86-7 |
9812710 6427057 |
Synonyms:
CARDOMEC
CD5024
CD-5024
EQVALAN
Heartgard®|ivermectin B<sub>1a</sub>|MK-933|Sklice®|Soolantra®
HEARTGUARD
IVERMECTIN
IVERMECTIN COMPONENT B1A
Ivermectina
Ivermectine
|
Ivermectinum
IVOMEC
L 640471
L-640471
MECTIZAN
MK 933
MK-933
SKLICE
SOOLANTRA
STROMECTOL
|
|
3 |
|
Anti-Bacterial Agents |
|
Phase 4 |
|
|
|
4 |
|
Anti-Infective Agents |
|
Phase 4 |
|
|
|
5 |
|
Antiparasitic Agents |
|
Phase 4 |
|
|
|
6 |
|
Albendazole |
Approved, Vet_approved |
Phase 3 |
|
54965-21-8 |
2082 |
Synonyms:
(5-(Propylthio)-1H-benzimidazol-2-yl)carbamate methyl ester
(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester
5-(Propylthio)-2-carbomethoxyaminobenzimidazole
Albendazol
Albendazole
Albendazole armstrong brand
Albendazole diba brand
Albendazole fustery brand
Albendazole hormona brand
Albendazole liferpal brand
Albendazole monohydrochloride
Albendazole noé-socopharm brand
Albendazole pfizer brand
Albendazole sanicoopa brand
Albendazole valdecasas brand
Albendazolum
Albendoral
Albenza
Andazol
Armstrong brand OF albendazole
Bendapar
Bilutac
Diba brand OF albendazole
Digezanol
Disthelm
Disthelm, mediamix V
Endoplus
Eskazole
Fustery brand OF albendazole
|
Gascop
Hormona brand OF albendazole
Liferpal brand OF albendazole
Lurdex
Mediamix V disthelm
Metiazol
Monohydrochloride, albendazole
Noé socopharm brand OF albendazole
Noé-socopharm brand OF albendazole
NSC-220008
O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate
O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamic acid
Pfizer brand OF albendazole
Proftril
RICOBENDAZOLE
RYCOBENDAZOLE
Sanicoopa brand OF albendazole
SK And F 62979
SK And F62979
SK And F-62979
SK&F 62979
SK&F-62979
SmithKline beecham brand OF albendazole
V Disthelm, mediamix
Valbazen
Valdecasas brand OF albendazole
ZENTAL
Zentel
|
|
7 |
|
Diethylcarbamazine |
Approved, Investigational, Vet_approved |
Phase 3 |
|
90-89-1 |
3052 |
Synonyms:
Aventis brand OF diethylcarbamazine citrate
Camin
Carbamazine
Carbilazine
Citrate, diethylcarbamazine
Diethyl carbamazine
Diethylcarbamazin
Diethylcarbamazine
Diéthylcarbamazine
Diethylcarbamazine citrate
Diethylcarbamazine citrate (1:1)
Diethylcarbamazine citrate (1:2)
Diethylcarbamazine L-tartrate (1:1)
Diethylcarbamazine maleate
|
Diethylcarbamazine monohydrochloride
Diethylcarbamazine phosphate (1:1)
Diethylcarbamazinum
Dietilcarbamazina
Ditrazine base
Ethodryl
Hetrazan
Loxuran
Maleate, diethylcarbamazine
Monohydrochloride, diethylcarbamazine
N,N-Diethyl-4-methyl-1-piperazinecarboxamide
N,N-Diethyl-4-methylpiperazine-1-carboxamide
Notezine
|
|
8 |
|
Malathion |
Approved, Investigational |
Phase 3 |
|
121-75-5 |
4004 |
Synonyms:
[(Dimethoxyphosphinothioyl)thio]butanedioate diethyl ester
[(Dimethoxyphosphinothioyl)thio]butanedioic acid diethyl ester
8059HC
Carbafos
Carbofos
Carbophos
Compound 4049
Cythion
DERBAC-M
DIETHYL (DIMETHOXYPHOSPHINOTHIOYLTHIO) SUCCINATE
Diethyl (dimethoxyphosphinothioylthio)succinate
Diethyl (dimethoxyphosphinothioylthio)succinic acid
ENT 17,034
ENT-17034
Experimental insecticide 4049
Insecticide no. 4049
Karbofos
MALATHION
Malathione
Maldison
Mercaptosuccinic acid diethyl ester
|
Mercaptothion
Mercaptotion
MLT
NSC-6524
O,O-Dimethyl S-(1,2-bis(ethoxycarbonyl)ethyl)
O,O-Dimethyl S-(1,2-dicarbethoxyethyl) dithiophosphate
O,O-Dimethyl S-(1,2-dicarbethoxyethyl) dithiophosphoric acid
O,O-Dimethyl S-(1,2-dicarbethoxyethyl)phosphorodithioate
O,O-Dimethyl S-(1,2-dicarbethoxyethyl)phosphorodithioic acid
O,O-Dimethyl S-1,2-di(ethoxycarbamyl)ethyl
O,O-Dimethyldithiophosphate diethylmercaptosuccinate
O,O-Dimethyldithiophosphoric acid diethylmercaptosuccinic acid
Oleophosphothion
ORGANODERM
Ovide
Prioderm
QUELLADA-M
S-[1,2-BIS(ETHOXYCARBONYL) ETHYL]O,O-DIMETHYL-PHOSPHORODITHIOATE
Sadophos
SULEO-M
|
|
9 |
|
Permethrin |
Approved, Investigational |
Phase 3 |
|
52645-53-1 |
40326 |
Synonyms:
(3-Phenoxyphenyl)methyl (+-)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate
(3-Phenoxyphenyl)methyl (+-)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylic acid
(3-Phenoxyphenyl)methyl (±)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate
(m-Phenoxybenzyl)-cis,trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropane carboxylate, (3-phenoxyphenyl) methyl ester
3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropane carboxylic acid, (3-phenoxyphenyl) methyl ester
3-Phenoxybenzyl-(+-)-cis,trans-2,2-dichlorovinyl-2,2-dimethyl-cyclopropylcarboxylic acid, ester
3-Phenoxybenzyl-cis,trans-(1Rs)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
Ambush
cis Permethrin
cis-(1Rs)-Permethrin
cis-Permethrin
Cyclopropanecarboxylic acid, 3-(2,2-dichloroethenyl)-2,2-dimethyl-, (3-phenoxyphenyl)methyl ester
Elimite
LYCLEAR
LYTHRIN
Nittifor
NIX
NRDC 143
|
NRDC 147
NRDC143
NRDC-143
NRDC147
NRDC-147
PERMETHRIN
Permethrin, (1R-cis)-isomer
Permethrin, (1R-trans)-isomer
Permethrin, (1S-cis)-isomer
Permethrin, (1S-trans)-isomer
Permethrin, (cis-(+-))-isomer
Permethrin, (cis)-isomer
Permethrin, (trans-(+-))-isomer
Permethrin, (trans)-isomer
Permethrin, cis-(1Rs)-isomer
Permethrin, trans-(1Rs)-isomer
trans Permethrin
trans-(1Rs)-Permethrin
trans-Permethrin
|
|
10 |
|
Artenimol |
Approved, Experimental, Investigational |
Phase 3 |
|
71939-50-9 |
540327 |
Synonyms:
3alpha-Hydroxydeoxydihydroartemisinin
8alpha-Hydroxydeoxyartemisinin
9alpha-Hydroxydeoxyartemisinin
ARTEMETHER RELATED COMPOUND A
ARTENIMOL
beta-Dihydroartemisinin
DIHYDROARTEMISININ
|
Dihydroartemisinine
Dihydroqinghaosu
Dihydroquinghaosu
Dihydroquinghaosu, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10alpha,12alpha,12ar*))-isomer
Dihydroquinghaosu, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10beta,12alpha,12ar*))-isomer
GNF-PF-5634
|
|
11 |
|
Piperaquine |
Approved, Experimental, Investigational |
Phase 3 |
|
4085-31-8 |
|
Synonyms:
1,3-Bis(1-(7-chloro-4'-quinolyl)-4'-piperazinyl)propane
1,3-Bis(4-(7'-chloro-4'-quinoline)-1-piperazine)
1,3-Bis[4-(7-chloroquinolin-4-yl)piperazin-1-yl]propane
|
PIPERAQUINE
Piperaquinoline
|
|
12 |
|
Anthelmintics |
|
Phase 3 |
|
|
|
13 |
|
Neurotransmitter Agents |
|
Phase 3 |
|
|
|
14 |
|
Cholinesterase Inhibitors |
|
Phase 3 |
|
|
|
15 |
|
Cholinergic Agents |
|
Phase 3 |
|
|
|
16 |
|
Antimitotic Agents |
|
Phase 3 |
|
|
|
17 |
|
Tubulin Modulators |
|
Phase 3 |
|
|
|
18 |
|
Emollients |
|
Phase 3 |
|
|
|
19 |
|
Antiprotozoal Agents |
|
Phase 3 |
|
|
|
20 |
|
Antimalarials |
|
Phase 3 |
|
|
|
21 |
|
Benzocaine |
Approved, Investigational |
Phase 2 |
|
1994-09-7, 94-09-7 |
2337 |
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Carbethoxyaniline
Acetate, benzocaine
Aethoform
AEZODENT
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthin
Anestezin
Anesthesin
Anesthesine
Anesthone
ANTHISAN PLUS
AR01
AR-01
Baby anbesol
Bensokain
Benzoak
Benzocaina
BENZOCAINE
Benzocaine acetate
Benzocaine formate
Benzocaine hydrobromide
Benzocaine hydrochloride
Benzocaine methanesulfonate
Benzocainum
BURNEZE
CHILDREN'S CHLORASEPTIC
DEQUACAINE
Dermoplast
Diet ayds
Ethoform
Ethyl 4-aminobenzoate
|
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl aminobenzoic acid
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl p-aminophenylcarboxylic acid
Ethylester kyseliny P-aminobenzoove
Formate, benzocaine
Hurricaine
Hydrobromide, benzocaine
Hydrochloride, benzocaine
Identhesin
Keloform
LANACANE
MEDILAVE
Methanesulfonate, benzocaine
NESTOSYL
Norcain
Norcaine
NSC-41531
NSC-4688
Orabase-b
Ora-jel
ORAJEL
Orthesin
p-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
P-Aminobenzoic acid ethyl ester
Parathesin
Parathesine
p-Carbethoxyaniline
p-Ethoxycarboxylic aniline
Slim mint gum
Solarcaine
Solu H
Topcaine
TYROSOLVEN
TYROZETS
|
|
22 |
|
Tannic acid |
Approved |
Phase 2 |
|
1401-55-4 |
16129878 16129778 |
Synonyms:
Acid, tannic
ácido tánico
Acids, tannic
E181
FEMA NO. 3042
Gallotannic acid
|
Gallotannin
NSC-656273
TANNIC ACID
Tannic acids
Tannins
|
|
23 |
|
Moxidectin |
Approved, Investigational, Vet_approved |
Phase 2 |
|
113507-06-5 |
72728820 |
Synonyms:
5-Hydroxymilbemycin beta7
CL-301,423
CL-301423
Cydectin
Milbeknock
Milbemectin
Milbemycin a3
Milbemycin a4
Milbemycin alpha1
Milbemycin alpha10
Milbemycin alpha11
Milbemycin alpha13
Milbemycin alpha14
Milbemycin alpha15
Milbemycin alpha2
Milbemycin alpha3
Milbemycin alpha4
|
Milbemycin alpha5
Milbemycin alpha6
Milbemycin alpha7
Milbemycin alpha8
Milbemycin alpha9
Milbemycin b
Milbemycin beta1
Milbemycin beta12
Milbemycin beta2
Milbemycin beta3
Milbemycin D
Milbemycins
Mixture OF milbemycins a3 and a4
MOXIDECTIN
Moxidectina
Moxidectinum
|
|
24 |
|
Fennel |
Approved, Experimental |
Phase 2 |
|
|
|
Synonyms:
Fennel
Fennel, sweet
Florence fennel
|
Foeniculum vulgare top
Sweet fennel
|
|
25 |
|
English Lavender |
|
Phase 2 |
|
|
|
26 |
|
Liver Extracts |
|
|
|
|
|
27 |
|
Vaccines |
|
|
|
|
|
Interventional clinical trials:
(show all 33)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
A Randomized Controlled Trial Comparing the Effectiveness of Individual vs. Household Treatment for Scabies in Lambaréné, Gabon |
Completed |
NCT04205669 |
Phase 4 |
Benzyl Benzoate 25% Topical Application Lotion |
2 |
Impact of Combined Azithromycin and Ivermectin Mass Drug Administration for Yaws and Scabies - Impact on Impetigo and Skin Microbiology |
Completed |
NCT02775617 |
Phase 4 |
Ivermectin;Azithromycin;Permethrin |
3 |
A Single Treatment Pharmacokinetic and Safety Study of Natroba (Spinosad) Topical Suspension 0.9% w/w in Subjects 1 Month to 3 Years 11 Months of Age With an Active Scabies Infestation |
Recruiting |
NCT05310734 |
Phase 4 |
Spinosad Topical |
4 |
Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study) |
Not yet recruiting |
NCT05500326 |
Phase 4 |
Ivermectin Tablets |
5 |
Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children: a Cluster Multicenter Randomized Trial |
Unknown status |
NCT02407782 |
Phase 3 |
Ivermectin;Permethrin |
6 |
A Multi-center, Double-blind, Randomized, Parallel-group Study Comparing Permethrin Cream, 5% With Elimite™ in Patients With Active Scabies. |
Completed |
NCT02978508 |
Phase 3 |
Permethrin Cream, 5%;Elimite |
7 |
A Randomized, Double-Blind, Parallel-Design, Multiple-Site Study to Evaluate the Therapeutic Equivalence of Permethrin Cream, 5% to Elimite™ Cream 5% in the Treatment of Scabies |
Completed |
NCT02572986 |
Phase 3 |
Permethrin |
8 |
A Phase 3, Randomized, Double Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Natroba™ (Spinosad) for the Treatment of Scabies |
Completed |
NCT02485704 |
Phase 3 |
spinosad topical suspension, 0.9% |
9 |
A Randomized, Double-Blind, Parallel-Design, Multiple-Site Study to Evaluate the Therapeutic Equivalence of Permethrin Cream, 5% (Encube Ethicals) Compared to Elimite™ Cream (Permethrin) 5% (Prestium Pharma, Inc.) in the Treatment of Scabies |
Completed |
NCT03178942 |
Phase 3 |
Permethrin Cream, 5%;Elimite™ Cream (permethrin) 5% |
10 |
A Phase 3, Randomized, Double Blind, Placebo-Controlled Study to Assess the Safety, Efficacy and Pharmacokinetics of Natroba™ (Spinosad) for the Treatment of Scabies |
Completed |
NCT02485717 |
Phase 3 |
spinosad topical suspension, 0.9% |
11 |
Impact of Community Scabies Treatment on Head Lice Prevalence in the Solomon Islands |
Completed |
NCT03236168 |
Phase 3 |
Ivermectin;Permethrin 5%;Malathion Shampoo 0.5% |
12 |
A Double Blind, Two Arm, Multicenter, Randomized, Parallel Group, Bioequivalence Study With Clinical Endpoints to Evaluate the Safety and Therapeutic Equivalence of Permethrin Cream 5% & Elimite™ in Subjects With Scabies |
Completed |
NCT03973775 |
Phase 3 |
Permethrin Cream 5% |
13 |
A Cluster Randomised Trial of the Safety of Co-Administration of IDA (Ivermectin, Diethylcarbamazine and Albendazole) & Azithromycin for Integrated Treatment of Neglected Tropical Diseases |
Completed |
NCT03676140 |
Phase 3 |
Albendazole on Day 1;Ivermectin on Day 1;Diethylcarbamazine on day 1;Azithromycin on Day 1;Azithromycin on Day 8 |
14 |
Prospective, Open-label, Multicenter, Initially Single-armed and in Case of Treatment Failure Subsequently Three-armed Randomized Clinical Trial of Phase III/IV Investigating the Escalated Therapy of Scabies With INFECTOSCAB 5% (Permethrin) |
Recruiting |
NCT04814511 |
Phase 3 |
InfectoScab 5 % Creme;Permethrin 10 % Creme;Driponin 3 mg Tabletten |
15 |
A Randomized Controlled Double-blind Trial Assessing the Efficacy of a 400µg/kg Ivermectin /5% Permethrin / Emollient Cream Regimen in Patients With Crusted Scabies as Compared to a 200µg/kg Ivermectin /5% Permethrin /Emollient Cream Regimen |
Recruiting |
NCT02841215 |
Phase 3 |
Ivermectin 200 µg/kg;Ivermectin 400 µg/kg |
16 |
Adjunctive Ivermectin Mass Drug Administration for Malaria Control on the Bijagos Archipelago of Guinea Bissau: A Cluster-randomized Placebo-controlled Trial |
Recruiting |
NCT04844905 |
Phase 3 |
Ivermectin;Placebo;Dihydroartemisinin-piperaquine |
17 |
A Phase II, Randomized, Double-blind, Parallel Group Dose Finding Study of Single Oral Doses of Moxidectin in Adults With Scabies |
Completed |
NCT03905265 |
Phase 2 |
Moxidectin Oral Product |
18 |
A Randomised, Double Blind, Double Dummy Study to Compare the Efficacy and Safety of a Single Administration of Ivermectin to a Single Administration of Permethrin for the Treatment of Scabies |
Completed |
NCT00262418 |
Phase 2 |
Administration of ivermectin or permethrin |
19 |
A Multicenter, Randomized, Double-Blind, Parallel Group Comparison Study of the Safety and Efficacy of Permethrin Foam, 5% Versus Permethrin Foam, 4% Versus Vehicle in Subjects With Sarcoptes Scabiei |
Completed |
NCT02094716 |
Phase 2 |
Permethrin Foam 4%;Permethrin Foam 5%;Vehicle Foam |
20 |
A Randomised, Double-blind, Placebo-controlled Trial to Assess the Safety, Pharmacokinetics, and Efficacy of Escalating Doses of Oral Ivermectin in Scabies Infected Children Weighing 5 to Less Than 15 Kilograms |
Not yet recruiting |
NCT04332068 |
Phase 2 |
Oral ivermectin;Permethrin Cream |
21 |
Comparative Study Between Topical Permethrin 5% and Oral Ivermectin for the Treatment of Scabies |
Completed |
NCT05362513 |
Phase 1 |
Ivermectin Tablets;Permethrin Cream |
22 |
The Epidemiology of Group A Streptococcal Infections in Fiji (Fiji GrASP) - Part 4 -The Prevalence of Group A Streptococcal Pyoderma and Scabies in Infants in Fiji |
Completed |
NCT00436891 |
|
|
23 |
Veron Scabies Education and Eradication Program |
Completed |
NCT00604084 |
|
Ivermectin;Permethrin 5% lotion |
24 |
Community Based Safety Study of 2-drug (Diethylcarbamazine and Albendazole) Versus 3-drug (Ivermectin, Diethylcarbamazine and Albendazole) Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji |
Completed |
NCT03177993 |
|
3 drug dose - IDA;3 drug dose - IDA with second dose of ivermectin;2 drug dose - DA |
25 |
Better Disease Control by Multidrug Regimen in Scabies: A Randomized Controlled Trial |
Completed |
NCT05198947 |
|
Permethrin Lotion 5%;Permethrin Lotion 5% and Oral Ivermectin 200 mcg/kg |
26 |
The Epidemiology of Group A Streptococcal Infections in Fiji (Fiji GrASP) Part 3: The Incidence of Group A Streptococcal Pharyngitis and the Prevalence of Pyoderma and Scabies in School Children in Fiji, and Establishing Immunologic Correlates of Protection for a J8 Vaccine |
Completed |
NCT00284882 |
|
|
27 |
The Epidemiology of Group A Streptococcal Infections in Fiji (Fiji GrASP) Part 1: The Prevalence of Rheumatic Heart Disease, Pyoderma and Scabies in School Children in Fiji |
Completed |
NCT00284843 |
|
|
28 |
East Arnhem Healthy Skin Project: A Regional Collaboration to Reduce Scabies, Skin Sores and Associated Chronic Diseases, Including Rheumatic Fever and Renal Disease, Among Australian Aboriginal Communities |
Completed |
NCT00884728 |
|
|
29 |
Efficacy and Side Effects of Blacksoap® as Adjuvant Therapy of Scabies: a Single-blind Randomized Control Trial |
Completed |
NCT05025696 |
|
|
30 |
PCR (Polymerase Chain Reaction) Assay for Diagnosis of Sarcoptes Scabiei |
Completed |
NCT02254564 |
|
|
31 |
Streptococcus Pyogenes Carriage Acquisition, Persistence and Transmission Dynamics Within Households in The Gambia: a Longitudinal Cohort Study |
Completed |
NCT05117528 |
|
|
32 |
Risk Factors for Treatment Failure of Scabies in Autochthonous Populations of French Guiana (GUYAGALE) |
Recruiting |
NCT04931680 |
|
|
33 |
Place of Hygiene in Scabies's Treatment in Populations in Precarious Situations |
Not yet recruiting |
NCT05271968 |
|
|
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
ANISE OIL/CORIANDER OIL/LEMON OIL/ORANGE OIL
crotamiton
Ivermectin
|
Lindane
Permethrin
Piperonyl Butoxide
|
Cochrane evidence based reviews: scabies
|